• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Wellness

COVID-19 restrictions may improve sleep quality of narcolepsy and idiopathic hypersomnia patients

byJane ZenandAvneesh Bhangu
February 9, 2022
in Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this study, narcolepsy and hypersomnia patients reported an increase in sleep time and delays in bedtime (BT) and wake time (WT) during the COVID-19 pandemic lockdowns.

2. Narcolepsy patients reported significant improvements in cataplexy and sleep-related hallucinations during lockdowns.

Evidence Rating Level: 2 (Good)

Throughout the COVID-19 pandemic, strict regulations have been enforced in many countries to minimize the spread of the virus. Telework has normalized globally, and evidence has demonstrated profound alterations in human sleep patterns that emerged from this condition. In this observational cohort study, the impact of COVID-19 lockdown measures on sleep habits and symptoms of narcolepsy type 1 (NT1) and type 2 (NT2) and idiopathic hypersomnia (IH) patients in France was investigated.

A total of 219 (of 851 recruited) NT1, NT2, and IH patients from the Pitié-Salpétrière hospital, France completed a 78-question survey that assessed a variety of factors, including demographics, sleep habits, hypersomnia symptoms, and Epworth Sleepiness Scale (ESS) score, which measures excessive daytime sleepiness (scale 0-3, 0=no sleepiness, 3=high) in individuals. Participants who did not complete the survey were excluded from the study. Furthermore, this study looked at comparisons between patients who worked as teleworkers and in-person at their occupations.

Participants reported a significant increase in night sleep time and decrease in ESS. Furthermore, 46.1% of participants reported a delay in bedtime, and 59.6% of participants reported a delay in waketime (primarily by IH patients). Teleworkers reported a significant increase in night sleep and a mean decrease in sleepiness score. 54.1% of NT1 participants reported a decrease or disappearance in cataplexy, and a large percentage of NT1 and NT2 patients indicated decreases in sleep-related hallucinations. However, half of the respondents reported experiencing insomnia at some point during lockdowns. This study was limited in its low response rate (25.7%). Nonetheless, the study was significant in revealing the changes in sleep patterns, health, and severity of symptoms of hypersomnia patients that occurred during COVID-19 lockdown measures.

RELATED REPORTS

Oveporexton improves symptoms in patients with narcolepsy type 1

Worsening kidney function observed following SARS-CoV-2 infection in children

Hospital-onset antimicrobial resistance increased during COVID-19 pandemic

Click to read the study in Journal of Clinical Sleep Medicine

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: COVID-19hypersomniaNarcolepsyqualitysleep
Previous Post

The effect of inter-pregnancy interval on stillbirth in urban South Ethiopia

Next Post

Metformin may improve survival for advanced lung adenocarcinoma patients with higher BMI and taking EGFR-TKI therapy

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Oveporexton improves symptoms in patients with narcolepsy type 1

June 3, 2025
Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
High risk of complications, but low mortality among children with MRSA bacteremia
Infectious Disease

Hospital-onset antimicrobial resistance increased during COVID-19 pandemic

April 28, 2025
Career Development

Short sleep duration associated with increased risk of diabetes

March 14, 2025
Next Post
Metformin treats Fragile X syndrome symptoms in mice [PreClinical]

Metformin may improve survival for advanced lung adenocarcinoma patients with higher BMI and taking EGFR-TKI therapy

Neuroendocrine tumor marker pancreastatin may be predictive of survival

Imatinib and binimetinib combination is a potential effective treatment for advanced gastrointestinal stromal tumours

[Physician Comment] The extent of C. difficile infections may not differ in light of immune status

Oral microbiome therapy reduced Clostridioides difficile recurrence

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Weighted vests and resistance training confer similar outcomes for bone density in the elderly
  • Breast cancer survivors may have a lower risk of Alzheimer’s dementia
  • Evaluating scar outcomes in pediatric burn patients following skin grafting 
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.